Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)

被引:0
作者
Taylor M. Patek
Chengwen Teng
Kaitlin E. Kennedy
Carlos A. Alvarez
Christopher R. Frei
机构
[1] The University of Texas at Austin,Pharmacotherapy Division, College of Pharmacy
[2] The University of Texas Health Science Center at San Antonio,Pharmacotherapy Education and Research Center, Long School of Medicine
[3] Texas Tech University Health Sciences Center,Division of Clinical/Translational Research, Hodge School of Pharmacy
[4] South Texas Veterans Health Care System,undefined
[5] University Health System,undefined
来源
Drug Safety | 2020年 / 43卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:17 / 22
页数:5
相关论文
共 101 条
[1]  
Bellomo R(2012)Acute kidney injury Lancet. 380 756-766
[2]  
Kellum JA(2014)Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals Clin J Am Soc Nephrol. 9 12-20
[3]  
Ronco C(2015)Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study Intensive Care Med. 41 1411-1423
[4]  
Zeng X(2017)Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup Nat Rev Nephrol. 13 241-257
[5]  
McMahon GM(2014)Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill Am J Respir Crit Care Med. 189 1075-1081
[6]  
Brunelli SM(2010)Drug-induced acute kidney injury in the critically ill adult: recognition and prevention strategies Crit Care Med. 38 S169-S174
[7]  
Bates DW(2013)Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome Acta Med Iran. 51 871-878
[8]  
Waikar SS(2018)Vancomycin plus piperacillin–tazobactam and acute kidney injury in adults: a systematic review and meta-analysis Crit Care Med. 46 12-20
[9]  
Hoste EA(2018)Drug-associated acute kidney injury identified in the United States Food and Drug Administration Adverse Event Reporting System database Pharmacotherapy. 38 785-793
[10]  
Bagshaw SM(2001)Increasing threat of Gram-negative bacteria Crit Care Med. 29 N75-N81